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Mitogen withdrawal triggers myogenic differentiation in skeletal myoblasts in culture. We have examined the expression of the proto-oncogene 
c-JWI during this process in mouse C& myoblasts. c-jun belongs to a family of immediate arly genes whose expression is activated in cultured 
cells in response to the addition of serum growth factors. Interestingly, expression of c-jun was maintained in mouse C,C,, and rat L6 myoblasts 
undergoing myogenic differentiation under low-serum conditions. Previously it has been reported that expression of c-jun is downregulated uring 
differentiation of C2 cells. However, our results using C& cells, a subclone of the C2 line, show that c-jun mRNA, protein and the activator-protein 
1 (AP-1) DNA-binding activity were easily detected in proliferating myoblasts and differentiated myotubes. Although overexpression of c-jun has 
been shown to block myogenic differentiation in C2 cells, results presented here suggest hat expression of c-jun at physiological levels may not 
interfere with skeletal myogenesis. 
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1. INTRODUCTION 
Skeletal myoblasts grown in culture differentiate in 
response to depletion of exogenous growth factors. 
Upon mitogen withdrawal, myoblasts exit from the cell 
cycle, express various muscle-specific genes, and fuse 
together to from multinucleate myotubes. Since many 
events associated with cell commitment and terminal 
differentiation are well characterized in skeletal myob- 
lasts, these cells offer an excellent model for understand- 
ing the role of proto-oncogenes during cellular prolifer- 
ation and differentiation. In the recent years various 
studies have shown that the proto-oncogene c-&n plays 
an important role in cell growth and differentiation (re- 
viewed in [l]). 
The product of the proto-oncogene c-&n is a major 
component of the AP-1 complex [2,3]. In addition to 
homodimers, cJun forms heterodimers with Jun-B and 
Jun-D which are members of the jun family, and c-Fos, 
Fra-1, Fra-2 and Fos-B which are members of the fos 
family of proteins (reviewed in [4]). These dimers regu- 
late expression of target genes containing the AP-1 
binding site (TGACTCA). Expression of c-jun is regu- 
lated both at transcriptional and post-translational lev- 
els. Transcription of c-jun is regulated by various serum 
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growth factors, interleukin- 1, phorbol esters, cyclic 
AMP and other agents (reviewed in [l]). An AP-1 site 
present in the c-&n promoter mediates positive autoreg- 
ulation by AP-1 [5]. The DNA-binding activity of cJun 
is modulated by site-specific phosphorylation and 
dephosphorylation [6,7], and protein-protein interac- 
tions [1,8]. 
Using in situ hybridization techniques, it has been 
previously shown that c-&n mRNA is expressed in 14.5 
and 17.5day mouse embryo skeletal muscle [9]. Tran- 
scripts for the muscle regulatory factors MyoD and 
myogenin were also found to be expressed at this time 
[lo]. However, it is not known whether c-&n expression 
plays any role in skeletal myogenesis in vivo. To address 
whether c-&n is expressed uring terminal differentia- 
tion of skeletal muscle cells in culture we have previ- 
ously examined the expression of c-jun in rat skeletal L6 
myoblasts. Withdrawal of serum mitogen triggers ter- 
minal differentiation of skeletal myoblasts in culture. 
We have found that expression of c_junlAP-1 was main- 
tained during myogenic differentiation of L6 cells. No- 
tably, expression of c-&n was not markedly affected by 
addition of serum or depletion of the AP-1 binding 
activity by inhibiting protein synthesis in rat L6 cells (G. 
Thinakaran and J. Bag, unpublished results). 
The uncharacteristic expression of c-&n in rat L6 cells 
maintained in low-serum conditions prompted us to 
study its expression in another well characterized mus- 
cle cell line namely the mouse C+Z,,. Our results show 
that mouse CZCIZ myoblasts also express appreciable 
amounts of c-&n mRNA and cJun protein during dif- 
ferentiation. Gel retardation assays detected AP-1 bind- 
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ing activity in the nuclear extracts prepared from C,C,, 
cells. The finding that c-&n and various contractile pro- 
tein mRNAs were co-expressed in C2C,2 cultures dem- 
onstrate that expression of c-jun is compatible with 
myogenic differentiation of these cells. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Mouse skeletal C& cells (ATCC CRL 1772) were grown in Dul- 
becco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum (GIBCO). Rat skeletal L6 cells were grown in Alpha modified 
minimal essential medium supplemented with 10% fetal calf serum. 
Myotube formation was induced by the addition of medium contain- 
ing 2.5% horse serum (differentiation medium) to subconfluent cul- 
tures. Approximately 80-90% of the nuclei were present in myotubes 
34 days after the shift to the differentiation medium. 
2.2. RNA analyw 
Total cellular RNA was isolated by the acid guanidinium thiocya- 
nate method [l 11. Twenty micrograms of RNA was fractionated by 
formaldehyde-agarose gel electrophoresis and transferred to Zetabmd 
membrane (Cuno, Inc.). For dot blot analysis, RNA contained in 100 
,ul of water was mixed with 150 ~1 of formaldehyde solution (37%. 
w/w) and 150 ~1 of SSC (1 x SSC = 0.15 M NaCI. 0.015 M sodium 
citrate, pH 7.4), incubated at 65°C for 15 min and loaded onto Ze- 
tabind membrane using a Hybri-dot 96-well filtration manifold 
(BRL). 
Northern blotting was performed as described previously [12]. 
DNA probes specific to c-jun (an EcoRI fragment of pJac7) [13], 
MyoD (an EcoRI fragment of pVZCIIcc) [14], myogenin (an EcoRI 
fragment of pUC65-20) [15], actin (linearized plasmid p AC 269) [16] 
and glyceraldehyde-3-phosphate dehydrogenase (linearized plasmid 
pRGAPDH13) [17] were used for hybridizations. Synthetic oligode- 
oxynucleotides were used for fast troponin C (5’~CTCAGCCTGTT- 
GGTCCGT-3’) and fast troponin T (5’-TTCCTCGTCAGACAT-3’) 
hybridizations. Autoradiographic signals from appropriately exposed 
films were quantified using a video image processing system (GelPrint, 
BioPhotonics Corp.). The signal intensities were normalized using the 
amount of 28 S rRNA. quantified by ethidium bromide staining of the 
RNA in the gel prior to transfer. 
2.3. Measurement of the c-Jun poiypepilde levels 
Nuclear extracts were prepared as described previously [18]. The 
protein concentrations were determined using the BioRad protein 
assay kit. Western blotting was performed using a polyclonal c-Jun 
antibody (c-Jun/AP-1 Ab-1, Oncogene Science, Inc.) using an alkaline 
phosphatase system (ProtoBlot, Promega Corp.) according to the 
manufacturer’s instructions. 
2.4. Gel mobility shif assay 
Electrophoretic mobility shift assay was performed as described 
previously [19] using synthetic oligodeoxynucleotides containing the 
consensus AP-1 site (TGACTCA) [20] or a mutated AP-I site 
(TGCCTCA). Binding was carried out using 10 fig of nuclear extract 
and SiP-labelled oligodeoxynucleotides (20 fmol, =15,000 cpm) in 20 
~1 of binding buffer at room temperature for 20 mm. DNA-protein 
complexes were resolved on a 5% polyacrylamide gel. The gels were 
vacuum dried and exposed to Kodak XAR film. 
3. RESULTS 
Rat L6 cells express c-jun mRNA and protein during 
myogenic differentiation in low-mitogen medium (G. 
Thinakaran and J. Bag, unpublished results). To test 
whether expression of c-jun in low-serum conditions is 
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Fig. 1. Comparison of c-jun mRNA expression in L6 and C,C,2 cells. 
Subconfluent L6 and CzC,2 cultures were allowed to differentiate in 
the differentiation medmm. RNA isolated from proliferating myob- 
lasts (0) and differentiating cells maintained in the differentiation 
medium for the Indicated time were spotted onto nylon membrane and 
hybridized with radiolabeled c-jun probe as described in section 2. 
characteristic of all skeletal myoblasts, we examined the 
steady-state level of c-jun mRNA during differentiation 
in mouse C$Z,2 cells. As shown in Fig. 1, the level of 
c-&n mRNA expressed during proliferation and termi- 
nal differentiation was comparable in L6 and C&Z,, 
cells. When this work was in progress, it was reported 
that constitutive expression of c-jun blocked myogenic 
differentiation of C2 myoblasts [21]. Expression of c-jun 
mRNA was abolished during myogenic differentiation 
of the particular population of C2 cells used in that 
study. 
The C$& cells used in this study (obtained from the 
American Type Culture Collection) were derived from 
the original mouse C2 line established by Yaffe and 
Saxel [22,23]. Variations in the expression of proto- 
oncogenes between different subclones of a skeletal 
myoblast line have been reported previously [24]. There- 
fore, we decided to further investigate the expression of 
c-jun during myogenic differentiation of C,C,, cells. As 
shown in Fig. 2, the steady-state level of c-jun mRNA 
declined slightly during differentiation but cells main- 
tained in the differentiation medium for 15 days still 
contained detectable amounts of c-jun mRNA. The 
same membrane was used to measure the expression of 
MyoD and myogenin mRNAs. MyoD and myogenin 
belong to the Helix-Loop-Helix family of myogenic fac- 
tors [25]. MyoD mRNA was expressed at a low level 
during proliferation and differentiation of these cells 
(Fig. 2). Expression of myogenin was induced 12 h after 
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Fig. 2. Expression of c&n and muscle-specific mRNAs during C,C,, 
myoblast differentiation. Subconfluent C2CIz cultures were allowed to 
differentiate in the differentiation medium. Twenty micrograms of 
total RNA isolated at indicated times after addition of the differenti- 
ation medium was fractionated by formaldehyde-agarose g l electro- 
phoresis and blotted to a nylon filter. The same membrane was se- 
quentially hybridized with various probes. The Mb lane represents 
RNA from proliferating C& myoblasts. 
the shift to the differentiation medium indicating that 
myogenic differentiation was induced in these cultures. 
In addition to this early differentiation marker, expres- 
sion of muscle-specific genes uch as actin, fast troponin 
C, and fast troponin T were also examined (Fig. 2). 
Results of these studies demonstrated that mRNAs en- 
coding various muscle-specific proteins and c-Jun were 
co-expressed uring differentiation. It should be noted 
that significant levels of muscle mRNAs were expressed 
within two days in differentiation medium. As judged 
by the presence of multinucleated myotubes, nearly 90% 
of the cells were differentiated within three to four days 
under these conditions. Therefore, these results indicate 
that c-jun mRNA is expressed in differentiated C,Cr2 
muscle cells. 
The c-&n mRNA has been reported to be inefficiently 
translated in HeLa cells [5]. This is probably due to the 
presence of a long 5’ untranslated region measuring 
roughly 1 kb [26]. Since cJun protein has a half-life of 
about 90 min in various cell lines [27], measurement of 
the steady-state l vel by Western blot is a good estimate 
of its synthesis. We have therefore performed Western 
blots to determine whether the c-&n mRNA was trans- 
lated into its protein product in C& cells. Nuclear 
extracts prepared from proliferating and differentiating 
C2C,, cells were reacted with a polyclonal anti-cJun 
antibody. As shown in Fig. 3, the steady-state level of 
cJun polypeptide did not decline in C2Cr2 cells main- 
tained in the differentiation medium during the first 2 
days when expression of muscle specific genes and 
myoblast fusion occurred. Although the level of c-Jun 
decreased later, it could be easily detected even after 10 
days in the differentiation medium. 
Transient transfection assays performed in F9 cells 
indicated that MyoD could repress the transcriptional 
activity of cJun [21]. Therefore, although c-Jun pol- 
ypeptide was present in C&, cells during differentia- 
tion, it is possible that the AP-1 activity may be sup- 
pressed by MyoD and myogenin. To test this possibil- 
ity, we performed gel retardation assays with a double- 
stranded oligodeoxynucleotide containing 
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Fig. 3. Western blot analysis of c-Jun expression. Nuclear extracts (10 
&lane) isolated from proliferating C2Cn myoblasts (Mb) or cells 
maintained in the differentiation medium for the indicated time were 
subject o sodium dodecyl sulfate polyacrylamide gel electrophoresis. 
After transfer to nylon membranes, c-Jun protein was detected using 
a polyclonal c-Jun antibody as described in section 2. The band corre- 
sponding to cJun is marked with an arrowhead. Posttion of the 
migration of molecular weight markers (MW, in kDa) is also marked. 
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Fig. 4. Analysis of the AP-I binding activity in differentiating C,C,, 
cells. Nuclear extracts were prepared from subconfluent myoblasts (0) 
and cells undergoing myogenic differentiation. A synthetic AP-1 bind- 
ing site was used to assay the presence of the AP-1 binding proteins 
in 10 pug of each of the nuclear extracts. (B) A I-bp change in the AP-I 
binding site abolished specific complex but increased the formation of 
the nonspecific faster-migrating complex (marked with a dot). 
binding site. As shown in Fig. 4, the AP-1 oligomer 
readily formed one major complex with the C,C,, nu- 
clear proteins. Myoblasts and C,C,, cells maintained in 
the differentiation medium for up to 2 days contained 
similar amounts of AP-1 binding activity. Later this 
activity decreased but did not completely disappear 
even after 10 days. Experiments performed with an oli- 
gomer containing a 1 -bp change at the AP- 1 binding site 
(TGCCTCA) ascertained the specificity of the mobility- 
retarded complex (Fig. 4B). These results suggest that 
nuclear proteins of differentiating CzCIz cells expressing 
MyoD and myogenin could still form specific AP- 1 pro- 
tein complexes in vitro (compare Figs. 2,3 and 4). How- 
ever, AP-I activity gradually decreased when the differ- 
entiated cells were maintained in the low-serum medium 
for several days after differentiation. Since maximal ex- 
pression of myogenin and MyoD was observed within 
2 days and 90% of the cells were in a multinucleated 
state within 334 days in the differentiation medium, it 
is not clear whether this decrease in AP-1 activity is 
directly related to differentiation. It is interesting to 
note that the AP-1 activity in these cells did not corre- 
spond to the c-Jun polypeptide levels (Figs. 3 and 4). 
Thus, the slow decrease in AP-1 activity may be due to 
post-translational regulation of cJun function in differ- 
entiated cells. 
4. DISCUSSION 
Several observations uggest that expression of c-&n 
is associated with cellular proliferation [I ,281. Exponen- 
tially growing cells contain higher levels of c-&n mRNA 
than serum starved cells [5]. However, the high level 
expression of c-jun during differentiation of PC12 cells, 
myeloid leukemia cell lines and embryonal carcinoma 
cells indicate that c&n expression is not restricted to 
proliferating cells [29-321. Results presented here show 
that CC,, cells also expressed c-jun mRNA and cJun 
protein during proliferation and differentiation. 
Co-expression of c-jun and various muscle-specific 
genes during differentiation of C,C,, cells is consistent 
with similar results obtained in rat L6 myoblasts (un- 
published results). In contrast to these results, a recent 
report showed that c-jun mRNA was undetectable dur- 
ing differentiation of C2 myoblasts [21]. However, ex- 
pression of c-Jun protein and the AP-1 binding activity 
were not measured in differentiating C2 cells. It is not 
clear whether some differences in culture conditions 
could account for the marked discrepancy in the ob- 
served steady-state level of c-&n mRNA during differ- 
entiation of these cells. 
Our results show that, in addition to c-jun, the pattern 
of expression of MyoD was also different between C2 
and C,C,, cells. MyoD mRNA increased 5-fold during 
differentiation of C2 cells [21], whereas there was no 
marked difference in the steady-state level of MyoD 
mRNA in proliferating and differentiating C,C,2 cells 
used in our study (Fig. 2). This is not unusual because 
expression of MyoD has been previously found to be 
upregulated, maintained, or downregulated uring ter- 
minal differentiation in different populations of C2 and 
CC,, myoblasts [14,33,34]. In our studies, we have not 
seen a decrease in c-&n expression until the cells were 
fully differentiated (Figs. 2 and 3) which occurred be- 
tween days two and four in differentiation medium. 
Following differentiation there was a gradual decline of 
both c-jun expression and AP-1 activity. It is possible 
that the precise mechanism and temporal order of regu- 
lating c-jun expression and function might vary in dif- 
ferent cell lines. The molecular mechanism of this regu- 
lation may depend on the level and mode of regulation 
of a repertoire of regulatory factors during myogenesis. 
It is not known whether the differences observed be- 
tween C2 and C,C,, cells in the expression of c-jun and 
MyoD genes are related. Expression of MyoD inhibited 
transactivation of an AP- 1 -dependent reporter gene by 
cJun in F9 cells [21]. Interestingly, cJun also repressed 
transcriptional activation by MyoD and Myogenin in 
primary chicken muscle cells and lOT1/2 cells [21,35]. 
These reports concluded that the mutual repression of 
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Jun and MyoD depends on the ratio of these proteins 
present in the cells. Transcription of both c-jun and 
MyoD genes are positively autoregulated by their pro- 
tein products [5,36]. Therefore, small increases in the 
relative amounts of either protein could result in the 
amplification of its own expression and suppression of 
the other gene. It is possible that the increased expres- 
sion of MyoD during differentiation of C2 cells was 
responsible for abolishing c-jun expression by blocking 
the autoregulation of c-jun promoter by c-Jun/AP- 1. 
Using transient expression of c-jun in C2 myoblasts, 
it was shown that its overproduction could suppress 
MyoD expression and myogenic differentiation sup- 
porting the theory that an increase in the relative 
amount of one of these transcription factors suppresses 
the expression of the other gene [21]. Whether the con- 
tinued expression of c-jun during differentiation of 
C2C,z cells is the cause or result of the lack of an in- 
crease in MyoD expression remains to be determined. 
Despite the continued presence of c-jun/AP-1, expres- 
sion of myogenin and various contractile protein genes 
like a-actin, fast troponin C and fast troponin T (Fig. 
2) and myotube formation was normally induced in 
C,C,, cells upon mitogen withdrawal. Although cJun 
and MyoD could suppress each other’s activities in 
transient expression assays 1211, expression of c-&n at 
physiological levels does not appear to interfere with 
terminal differentiation of C2C,, cells. This is not sur- 
prising because it has been previously reported that only 
48% of MyoD present in myoblasts is subject to nega- 
tive regulation by interaction with cJun [21]. It is also 
possible that C,C,, cells utilize a c-@nlMyoD independ- 
ent pathway for establishing skeletal lineage commit- 
ment and terminal differentiation. 
In addition to MyoD, commitment o skeletal muscle 
lineage is regulated by myogenin [15,39], myf5 [40], 
MRF-4, also called herculin and myf-6 [38,41,42], and 
possibly other genes that are not yet identified. During 
embryogenesis the various myogenic factors exhibit dif- 
ferences in the spatial and temporal pattern of expres- 
sion [43,44]. Furthermore, established skeletal muscle 
cell lines express only subsets of the myogenic regula- 
tory factors indicating the presence of multiple path- 
ways for myogenic commitment and differentiation. 
Therefore, analysis of c-&n expression in different es- 
tablished skeletal myoblasts might lead to a better un- 
derstanding of its possible role in terminal differentia- 
tion of skeletal muscle cells. 
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